Products
2660 products
Code | Description | Unit |
---|---|---|
EPY0000136 | Enilconazole | EP unit |
EPY0000137 | Enilconazole impurity E - (1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol | EP unit |
EPY0000138 | Flubendazole | EP unit |
EPY0000139 | Flubendazole for system suitability | EP unit |
EPY0000140 | Ibuprofen impurity F - 3-[4-(2-methylpropyl)phenyl]propanoic acid | EP unit |
EPY0000141 | Ioxaglic acid | EP unit |
EPY0000142 | Ioxaglic acid impurity A - 3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid | EP unit |
EPY0000143 | Malic acid - Reference Spectrum | EP unit |
EPY0000144 | Mebendazole for system suitability | EP unit |
EPY0000145 | Metoprolol impurity A - (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | EP unit |
EPY0000146 | Nadolol | EP unit |
EPY0000147 | Phenylbutazone impurity B - (4-butyl-4-hydroxy-1,2-diphenyl-3,5)pyrazolidinedione | EP unit |
EPY0000149 | Rifabutin | EP unit |
EPY0000151 | Tianeptine sodium - Reference Spectrum | EP unit |
EPY0000152 | Tianeptine for system suitability | EP unit |
EPY0000153 | Tianeptine impurity A - ethyl 7-bromoheptanoate | EP unit |
EPY0000154 | Tolfenamic acid | EP unit |
EPY0000155 | Tramadol hydrochloride | EP unit |
EPY0000156 | Tramadol impurity A - (1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol | EP unit |
EPY0000157 | Tramadol impurity E - (2RS)-2-[(dimethylamino)methyl]cyclohexanone | EP unit |
EPY0000158 | Xylazine impurity C - 2,6-dimethylphenyl isothiocyanate | EP unit |
EPY0000161 | Ketotifen impurity G - 4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)thiophen-9,10-dione | EP unit |
EPY0000162 | Cocaine hydrochloride - Reference Spectrum | EP unit |
EPY0000163 | Doxylamine hydrogen succinate - Reference Spectrum | EP unit |
EPY0000167 | Benzyl alcohol | EP unit |
EPY0000169 | Flunitrazepam - Reference Spectrum | EP unit |
EPY0000171 | Metoprolol succinate - Reference Spectrum | EP unit |
EPY0000172 | Apomorphine hydrochloride - Reference Spectrum | EP unit |
EPY0000173 | 4-Aminobenzoic acid | EP unit |
EPY0000176 | Cineole | EP unit |
EPY0000177 | Erythritol | EP unit |
EPY0000179 | Proguanil hydrochloride - Reference Spectrum | EP unit |
EPY0000181 | Proguanil impurity C - 1,5-bis(4-chlorophenyl)biguanide | EP unit |
EPY0000182 | Proguanil impurity D - 1,5-bis(1-methylethyl)biguanide | EP unit |
EPY0000184 | Rifabutin impurity A - 1-(2-methylpropyl)piperidin-4-one | EP unit |
EPY0000185 | Squalane | EP unit |
EPY0000186 | Hydroxypropylbetadex | EP unit |
EPY0000187 | Rilmenidine for system suitability | EP unit |
EPY0000190 | N-Methylpyrrolidone - Reference Spectrum | EP unit |
EPY0000191 | Human glucagon | EP unit |
EPY0000192 | Carteolol hydrochloride - Reference Spectrum | EP unit |
EPY0000193 | Carteolol for system suitability (Carteolol monohydrochloride) | EP unit |
EPY0000194 | Goserelin validation mixture | EP unit |
EPY0000195 | Ondansetron impurity D - 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one | EP unit |
EPY0000196 | Ondansetron for TLC system suitability | EP unit |
EPY0000197 | Ondansetron for LC system suitability | EP unit |
EPY0000198 | Ciprofloxacin | EP unit |
EPY0000199 | Ciprofloxacin hydrochloride for peak identification | EP unit |
EPY0000200 | Bromhexine impurity C - N-(2-aminobenzyl)-N-methylcyclohexanamine | EP unit |
EPY0000202 | Mexiletine impurity C - 1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine | EP unit |
EPY0000203 | Mexiletine impurity D - (2RS)-2-(2,6-dimethylphenoxy)propan-1-amine | EP unit |
EPY0000204 | Pravastatin 1,1,3,3-tetramethylbutylamine | EP unit |
EPY0000205 | Clobazam - Reference Spectrum | EP unit |
EPY0000207 | Perindopril for stereochemical purity | EP unit |
EPY0000208 | Doxapram impurity B - (4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one | EP unit |
EPY0000209 | Colchicine for system suitability | EP unit |
EPY0000210 | Sodium polystyrene sulphonate - Reference Spectrum | EP unit |
EPY0000211 | Flurazepam monohydrochloride - Reference Spectrum | EP unit |
EPY0000215 | Pravastatin sodium - Reference Spectrum | EP unit |
EPY0000216 | Dihydrocodeine hydrogen tartrate - Reference Spectrum | EP unit |
EPY0000217 | Diethylene glycol (monoethyl ether) - Reference Spectrum | EP unit |
EPY0000218 | Ondansetron hydrochloride dihydrate | EP unit |
EPY0000219 | Human anti-D immunoglobulin BRP | EP unit |
EPY0000220 | Roxithromycin for system suitability | EP unit |
EPY0000221 | Fluticasone impurity D - S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17a-propionyloxy-androsta-1,4-diene-17 beta-carbothioate (S-methyl derivative) | EP unit |
EPY0000222 | Moxonidine impurity A - 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine | EP unit |
EPY0000223 | Pravastatin impurity A - (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid (6'-epipravastatin) | EP unit |
EPY0000224 | Oxfendazole impurity B - methyl[5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate | EP unit |
EPY0000225 | Oxfendazole with impurity D | EP unit |
EPY0000226 | Moxonidine | EP unit |
EPY0000227 | Meso-rich exametazime | EP unit |
EPY0000228 | Demethylflumazenil - Reference Spectrum | EP unit |
EPY0000229 | Phenylmercuric acetate - Reference Spectrum | EP unit |
EPY0000232 | Dihydralazine for system suitability (Dihydralazine sulfate) | EP unit |
EPY0000233 | Paroxetine impurity A - (3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine (desfluoroparoxetine) | EP unit |
EPY0000234 | N,N-Dimethylacetamide - Reference Spectrum | EP unit |
EPY0000235 | Almagate | EP unit |
EPY0000236 | Fluspirilene | EP unit |
EPY0000237 | Perindopril impurity A - (2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid | EP unit |
EPY0000238 | Perindopril tert-butylamine | EP unit |
EPY0000239 | Celiprolol for peak identification | EP unit |
EPY0000240 | Cefapirin sodium | EP unit |
EPY0000241 | Clobazam impurity A - 7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione | EP unit |
EPY0000242 | Glibenclamide impurity B - methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl] sulphonyl]carbamate | EP unit |
EPY0000244 | Ketobemidone impurity B - B 1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone | EP unit |
EPY0000245 | Ketobemidone impurity C - 1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one | EP unit |
EPY0000246 | Ketobemidone hydrochloride - Reference Spectrum | EP unit |
EPY0000247 | Ebastine impurity C - 4-(diphenylmethoxy)piperidine | EP unit |
EPY0000248 | Ebastine impurity D - 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one | EP unit |
EPY0000249 | Ebastine - Reference Spectrum | EP unit |
EPY0000250 | Rilmenidine dihydrogenophosphate - Reference Spectrum | EP unit |
EPY0000251 | Molgramostim | EP unit |
EPY0000254 | Econazole for system suitability | EP unit |
EPY0000255 | Almagate - Reference Spectrum | EP unit |
EPY0000256 | Paroxetine impurity D - (3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine ((+)-trans-paroxetine) | EP unit |
EPY0000257 | Lactobionic acid | EP unit |
EPY0000258 | Diphtheria toxin BRP | EP unit |
EPY0000259 | Diclazuril for system suitability | EP unit |
EPY0000261 | Dextromethorphan impurity A - ent-3-methoxymorphinan | EP unit |
EPY0000263 | Prekallikrein activator in albumin BRP | EP unit |